secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2025-11-24T23:59:59+00:00
Accession:  0001437749-25-036082
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech furnishes November 2025 corporate presentation; content not disclosed in filing text
--------------------------------------------------------------------------------

- Filing under Item 7.01: corporate presentation posted on company website as Exhibit 99.1.
- Presentation date: November 2025. No specific financial or operational data included in the filing.
- Company ticker: MBRX (NASDAQ). No changes in guidance, earnings, or leadership disclosed.
- Given absence of presentation content, material impact cannot be assessed from this filing alone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925036082/0001437749-25-036082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925036082/mbrx20251121c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-036082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer